Thermo Fisher Scientific, an Indianapolis-based company that focuses on therapeutic drug management, is using its expertise in developing assays to help doctors properly dose antibiotics for methicillin-resistant Staphylococcus aureus infections. Its subsidiary, Remel, is also working on a test that would offer immediate detection of MRSA infection.

Related Summaries